Startupalooza NJ is a competition in which technology, digital health and medical device companies competed for the chance to present their products before a wider audience of private equity investors in New York next month. This is one of a series of posts I’m publishing that includes elevator pitches from three of the companies I liked.
Cancerlife is a social platform for cancer centers and their patients to communicate with supporters such as friends, family, people who share their disease and physicians. Users keep a journal of how they are feeling. But what sets Cancerlife apart from rival programs, says its president and cofounder, Charles Coltman, is that patients can track the side effects they experience from their medications, which allows them to work with their physicians to better tailor the level and types of medication they take.
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
The company currently has two monetization avenues: pharmaceutical companies and research organizations who want to better understand the effects of certain drugs on patients; and cancer centers, which under new guidelines are now required to better manage cancer patients’ physiological care when they go into distress. Although patient data is provided without identifying information, users are given the choice of opting out.
The company is launching into three oncology practices next month in Florida, New York and New Jersey, and is currently looking for beta testers. It was recently accepted into a new Philadelphia incubator called Seed Philly.